MohamedA(Kharfan-Dabaja)Kharfan DabajaMD

Mayo Clinic in Florida

Dr. Kharfan Dabaja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1996 - 1999
American University of Beirut Faculty of MedicineClass of 1995

PubMed

104 citations
Cytokine Release Syndrome: Current Perspectives
Hemant S. Murthy, Madiha Iqbal, Julio C. Chavez, Mohamed A. Kharfan-Dabaja
Immunotargets and Therapy. 2019-10-29
52 citations
Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.
Ambuj Kumar, Asmita R. Mhaskar, Tea Reljic, Rahul Mhaskar, Mohamed A. Kharfan-Dabaja
Leukemia. 2012-04-01
8 citations
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, Evandro D Bezerra, Juan Esteban Garcia-Robledo
Clinical Lymphoma, Myeloma & Leukemia. 2023-06-01

Abstracts/Posters

A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...
Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...
Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center f...
Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis
Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all